Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients

Tamás Szerafin1, Ambrus Horvath, Bernhard Moser

  • 1Department of Cardiac Surgery, University of Debrecen, Debrecen, Hungary.

Clinical Laboratory
|July 4, 2006
PubMed

Insights

Epithelial/endothelial apoptosis occurs during coronary artery bypass graft (CABG) surgery, regardless of whether it is performed on-pump or off-pump. This finding highlights cellular damage during cardiac procedures.

Area of Science:

  • Cardiovascular Surgery
  • Cellular Biology
  • Biomarkers

Background:

  • The relationship between epithelial/endothelial apoptosis and death-inducing receptors (DIR) versus vascular adhesion molecules during coronary artery bypass graft (CABG) surgery is unclear.
  • Investigating these markers can provide insights into cellular stress during cardiac procedures.

Purpose of the Study:

  • To investigate epithelial/endothelial apoptosis and the secretion of death-inducing receptors (DIR) and vascular adhesion molecules.
  • To compare these markers in patients undergoing on-pump versus off-pump CABG.

Main Methods:

  • Prospective study of 30 patients (15 on-pump CABG, 15 off-pump CABG).
  • Serum samples collected preoperatively and at 30 minutes, 60 minutes, and 24 hours post-CABG.
  • ELISA used to measure caspase-cleaved cytokeratin-18 (CK18), soluble VCAM-1, ICAM-1, TNFR-1, and CD95.

Main Results:

  • Soluble caspase-cleaved CK18 increased post-CABG, returning to baseline by 24 hours.
  • Soluble ICAM-1 significantly decreased at 30 and 60 minutes post-CABG.
  • Soluble TNFR-1/CD95 showed a non-significant increase compared to preoperative levels.

Conclusions:

  • Epithelial/endothelial apoptosis occurs in patients undergoing CABG surgery.
  • Apoptosis is observed irrespective of whether the CABG procedure is performed on-pump or off-pump.
  • The study provides novel evidence of cellular apoptosis during bypass operations.
Abstract

Related Concept Videos